Risk factors are multifocality, infiltration of the thyroid gland, histological variants of papillary thyroid carcinoma, low degree of differentiation, tumor diameter 6–10 mm, molecular markers like BRAF-V600E mutation, infiltrative tumor growth, surrounding desmoplastic fibrosis and previous percutaneous irradiation of the neck [14]. This evidence concerns the gene BRAF and neoplasm.